Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    NANO.PA Gross Margin

    As of 2025-06-01, the Gross Margin of Nanobiotix SA (NANO.PA) is 100%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    NANO.PA Gross Margin - Historical Value
    DateValue
    2024-12-31 100%
    2023-12-31 -
    2022-12-31 -
    2021-12-31 -
    2020-12-31 -
    2019-12-31 -
    2018-12-31 -
    2017-12-31 -
    2016-12-31 -
    2015-12-31 -
    NANO.PA Gross Margin - Peers Comparison
    TickerNameValue
    ABVX.PAAbivax SA-19700%
    ALBPS.PABiophytis SA7775.2%
    ALCLS.PACellectis SA7%
    ALNOV.PANovacyt SA32.2%
    BGBIO.OLBergenbio ASA100%
    BINV.STBioInvent International AB42.4%
    BVXP.LBioventix PLC93.2%
    CANTA.STCantargia AB7775.2%
    DBV.PADbv Technologies SA83.6%
    DMYD B.STDiamyd Medical AB-10161.5%
    FYB.DEFormycon AG20.3%
    HNSA.STHansa Biopharma AB51.2%
    HPHA.DEHeidelberg Pharma AG74%
    IPH.PAInnate Pharma SA94.5%
    IVA.PAInventiva SA146.3%
    IVACC.STIntervacc AB-29.9%
    KDS.ASKiadis Pharma NV-
    MAB.WAMabion SA59.6%
    MOLN.SWMolecular Partners AG99.8%
    NANOV.OLNordic Nanovector ASA7775.2%
    ORPHA.COOrphazyme A/S7775.2%
    ORY.MCOryzon Genomics SA-4700%
    OSE.PAOSE Immunotherapeutics SA100%
    SCLP.LScancell Holdings PLC90.1%
    SIGHT.PAGensight Biologics SA188.4%
    SLN.LSilence Therapeutics PLC3133.8%
    SNG.LSynairgen PLC68.8%
    TILS.LTiziana Life Sciences PLC63.2%
    TNG.PATransgene SA-701%
    VLA.PAValneva SE41.9%
    VVY.ASVivoryon Therapeutics NV85.4%
    XBRANE.STXbrane Biopharma AB90.8%
    XSPRAY.STXSpray Pharma AB (publ)2539.9%
    Tickers added to watchlist